St. Petersburg, FL, United States of America

Matt Ewert

This inventor holds 14 USPTO granted patents and 7 published patent applications and 4 EPO patents. Top assignee: University of South Florida. Active years: 2008-2015.

USPTO Granted Patents = 14 (Patent Applications = 7)

% Patents Active = 28.6

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 1.3

ph-index = 5

Forward Citations = 59(Granted Patents)

Location History:

St. Pete Beach, FL (US) (2008)
Seminole, FL (US) (2011)
St. Petersburg Beach, FL (US) (2013)
St. Petersburg, FL (US) (2011 - 2015)

Company Filing History:

14 out of 1,984

University of South Florida

patents

Years Active: 2008-2015

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8962243 - Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA (2015-02-24),

2. 8927243 - Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA (2015-01-06),

3. 8916698 - Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA (2014-12-23),

4. 8815502 - Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA (2014-08-26),

5. 8785176 - Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA (2014-07-22),

6. 8759479 - Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA (2014-06-24),

7. 8735090 - Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA (2014-05-27),

8. 8617839 - Early detection of pathogens in blood (2013-12-31),

9. 8592200 - Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA (2013-11-26),

10. 8574866 - Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA (2013-11-05),

11. 8465966 - Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA (2013-06-18),

12. 7998699 - Early detection of pathogens in blood (2011-08-16),

13. 7993870 - Early detection of pathogens in blood (2011-08-09),

14. 7416843 - Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA (2008-08-26),

Title: Matt Ewert: Innovator in Pathogen Extraction Technologies

Introduction

Matt Ewert is a distinguished inventor based in St. Petersburg, FL (US). He has made significant contributions to the field of biotechnology, particularly in the extraction of infectious pathogens from blood samples. With a total of 14 patents to his name, Ewert's work has the potential to impact medical diagnostics and treatment.

Latest Patents

Among his latest patents, Ewert has developed innovative methods for post-protein hydrolysis removal of a potent ribonuclease inhibitor. His inventions also include the enzymatic capture of DNA, which focuses on extracting infectious pathogens from a volume of blood. In one embodiment of his method, he creates a fibrin aggregate that confines the pathogens and introduces a fibrin lysis reagent to expose the pathogens for analysis. Additionally, his work addresses the removal of aurintricarboxylic acid (ATA) from samples, showcasing his commitment to advancing medical technology.

Career Highlights

Ewert has worked with notable institutions such as the University of South Florida and Imigene, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research in pathogen extraction technologies.

Collaborations

Some of Ewert's notable coworkers include Andrew C Cannons and Philip Amuso. Their collaborative efforts have contributed to the development of innovative solutions in biotechnology.

Conclusion

Matt Ewert's contributions to the field of biotechnology through his patents and collaborations highlight his role as a key innovator in pathogen extraction technologies. His work continues to pave the way for advancements in medical diagnostics and treatment.